Fanconi Anemia, Complementation Group N; Fancn
Description
Fanconi anemia (FA) is a clinically and genetically heterogeneous disorder that causes genomic instability. Characteristic clinical features include developmental abnormalities in major organ systems, early-onset bone marrow failure, and a high predisposition to cancer. The cellular hallmark of FA is hypersensitivity to DNA crosslinking agents and high frequency of chromosomal aberrations pointing to a defect in DNA repair (summary by Deakyne and Mazin, 2011).For additional general information and a discussion of genetic heterogeneity of Fanconi anemia, see {227650}.
Clinical Features
Top most frequent phenotypes and symptoms related to Fanconi Anemia, Complementation Group N; Fancn
- Microcephaly
- Growth delay
- Hypertelorism
- Neoplasm
- Failure to thrive
- Anemia
- Epicanthus
- Ventricular septal defect
- Short neck
- Atrial septal defect
And another 18 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Fanconi Anemia, Complementation Group N; Fancn Recommended genes panels
| Panel Name, Specifity and genes Tested/covered |
|---|
 Hereditary Brain, CNS, PNS Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
100 % |
|
Hereditary High Risk Breast Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 % |
|
Hereditary Brain, CNS, PNS Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
100 % |
|
Hereditary High Risk Breast Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BRCA1, BRCA2, STK11, TP53, CDH1, PALB2, PTEN
Specificity
15 %
Genes
100 % |
|
Hereditary Pancreatic Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDK4, CDKN2A, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, ATM, PMS2, RAD50
Specificity
6 %
Genes
100 % |
|
Hereditary Leukemia/Lymphoma Panel.
By Baylor Miraca Genetics Laboratories (United States).
RUNX1, BRCA2, TP53, CBL, CEBPA, SBDS, BRIP1, PALB2, GATA2, ATM, PAX5, PRF1, PTPN11
Specificity
8 %
Genes
100 % |
|
Comprehensive Hereditary Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
RUNX1, SDHA, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, VHL, WT1, CBL, SUFU, CDC73, CDH1, CDK4, CDKN1C, CDKN2A , (...)
View the complete list with 39 more genes
Specificity
2 %
Genes
100 % |
|
Hereditary Colorectal/Gastrointestinal Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, PALB2, ENG, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, ATM, PMS1, PMS2 , (...)
View the complete list with 1 more genes
Specificity
5 %
Genes
100 % |
You can get up to 230 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
MESH OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18 TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND OTHER ABNORMALITIES SPINOCEREBELLAR ATAXIA 28; SCA28 CURRARINO SYNDROME EHLERS-DANLOS SYNDROME DUE TO TENASCIN-X DEFICIENCY METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ